All Things Cardio-Oncology: Recent Episodes
International Cardio-Oncology Society
Here is a resource for expanding your understanding of the growing field of cardio-oncology in all its dimensions
Dr. Gagan Sahni Director of Cardio- Oncology and Inpatient Cardiology Consult services at Mount Sinai Hospital in NYC, and Fellow of ICOS presents her Center of Excellence quality improvement project.
Anecita Fadol who is Associate Professor, Education Director- Nursing Cardiology Program · The University of Texas MD Anderson Cancer Center and chair of the ICOS nurses Working Group
Jessica Coviello, DNP, APRN(Ct), ANP-BC, FAAN, Associate Dean of Faculty Development, Professor, Graduate Studies, Univ of TX School of Nursing in Houston
Dr. Carrie Lennemam, University of Alabama Birmingham explains how they are using AI to expedite referrals to their cardio-oncology clinic, saving time and saving lives.
Dr. Eric Yang, Director of Cardio-Oncology discusses how they have integrated cardio-oncology training into all aspects of their program for residents and fellows.
Dr Zsofia Drobni is a Cardiology Fellow at Semmelweis University, Budapest, HU. Her research focuses on the utility of cardiac CT and MRI in patients receiving cardiotoxic therapies, with a specific focus on immune checkpoint inhibitors. Dr Drobni graduated in 2017 from Semmelweis University, in Hungary, and continued her PhD studies at Semmelweis. Her PhD thesis was on “new perspectives of CT-based cardiovascular risk assessment”.From 2019, Dr Drobni was a research fellow at the Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard University. Dr Drobni is currently the president of and founded the Hungarian Chapter of IC-OS.
Dr Prince Otchere, MD, MPH is an Assistant Professor at the University of Texas Health where he co-directs the cardio-oncology programme.He is working with physicians in Ghana to create a National Cardio-Oncology Society and is also helping develop cardio-oncology programmes in two teaching hospitals in Ghana.His research interest involves creating and refining cardiac risk prediction models to anticipate patients who are at risk of cardiotoxicity.
Watch Full Webinar Here:
https://www.radcliffecardiology.com/webinars/cardiac-risk-prediction-model-patients-her-2-positive-breast-cancer-trastuzumab-therapy#
Read Dr. Otchere's award winning paper here:
https://cardiooncologyjournal.biomedcentral.com/articles/10.1186/s40959-023-00177-y
Dr Tamar Polonsky (The University of Chicago, US), explores the implications, diagnostic strategies and potential interventions for addressing incidental atherosclerosis in the journey of cancer care.
Watch Full Webinar Here:
https://www.radcliffecardiology.com/webinars/approach-incidental-atherosclerosis-cts-cancer-patients
Dr. Eiman Jahangir
Associate Professor of Medicine
Division of Cardiovascular Medicine
Director, Cardio-Oncology
Vanderbilt University Medical Center
In this episode Dr. Janhangir describes how he was selected to fly with Blue Origin to sub-orbital space fulfilling a lifelong dream. We also discuss the intersection of his work as a physician with his background in space science and the humanities.
Dr. Hyeon-Ju Ali Assistant Professor, Department of Cardiology,, MD Anderson Cancer Center, Houston, TX discusses her research and experience in a complex and challenging area of clinical care.
Read more on this subject:
Chronic thromboembolic pulmonary hypertension suspicion after pulmonary embolism in cancer patients
https://www.sciencedirect.com/science/article/abs/pii/S2590041219300248
Mechanical Venous Thrombectomy for Deep Venous Thrombosis in Cancer Patients: A Single-Center Retrospective Study
https://link.springer.com/article/10.1007/s00270-024-03691-3
Among other things Dr. Lang and Dr. Dan Lenihan discuss blood pressure treatments for patients with cancer.
For more information on the work Dr. Lang and his team are engaged in see: https://www.gla.ac.uk/schools/cardiovascularmetabolic/research/cardiac-diseases/oncology/#publications
Dr. Thavendiranathan discusses the HIMILAYAS trial, looking at exercise interventions for cancer survivors and the STOPMEDCTRCD trial addressing the ongoing efficacy of continuing use of cardiovascular medicines after cancer therapy
Dr. Paaladinesh Thavendiranathan is a cardiologist at the Toronto General Hospital, University Health Network; Associate Professor of medicine at the University of Toronto and a Clinician Investigator.
Learn more about the HIMILAYAS trial here:
https://www.himalayastrial.ca/
Learn more about the STOPMEDCTRCD trial here:
https://classic.clinicaltrials.gov/ct2/show/NCT06183437
Dr. Neilan discusses the largest randomized trial in the ICI therapy space, the ATRIUM trial.
Tom Neilan, MD, MPH Director, Cardio-Oncology Program
Co-Director, Cardiac MR PET CT Program
Learn more about the ATRIUM trial here:
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2022-04887
Karlis Trusinskis, MD President of IC-OS Latvia chapter speaks about the challenges and opportunities of cardio-oncology care in his country.
Diego Sadler, MD
Section Head Cardio Oncology, Cleveland Clinic Florida
In this episode Dr. Sadler speaks about his pioneering work with the Global Cardio-Oncology Registry. This is the first in kind registry that aims to enroll cardio-oncology patients from around the world. GCOR is a multinational, multicenter prospective observational cohort registry and will collect clinical, laboratory, imaging, demographic and socioeconomic data to identify risk factors associated with increased incidence of cancer therapy related cardiovascular disease.
Dr. Anju Nohria is the Director of the Cardio-Oncology Program at Dana-Farber Brigham Cancer Center and a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH). In addition, she is an Assistant Professor of Medicine at Harvard Medical School (HMS).
On this episode she discusses the challenges and opportunities of starting a new clinic focused on cardio-oncology care.
Renato Lopes, MD, PhD, FACC
Renato Delascio Lopes
Professor of Medicine
Duke University, School of Medicine
Professor of Medicine Divisions of Internal Medicine and Cardiology, Federal University of Sao Paulo, Sao Paulo, Brazil
Dr. Lopes discusses his ongoing efforts to develop, produce, and distribute cardio-oncology education in Brazil and the United States.
Dr Vivek Narayan is an Assistant Professor of Medicine at Hospital of the University of Pennsylvania, Philadelphia, US.
View the entire webinar here:
https://www.radcliffecardiology.com/video-index/renal-cell-carcinoma-and-vegf-tki-cardiovascular-toxicity
Richard Cheng MD, MSc. is cardiology faculty at the University of Washington, Seattle, with a focus in cardiomyopathies, cardio-oncology and cardiac imaging. He is Program Director for the HF fellowship and the Director of the Cardio-oncology Program. He has formal training with a Masters-in-Science in clinical trial design and biostatistics. He has extensive editorial experience, including serving on the editorial boards for JACC, JACC: Cardio-oncology, JHLT, and is an associate editor for Heart (BMJ). Additionally, he is topic (section) editor for cardiomyopathies for ACC/HFSA HFSAP and an associate editor for ACC.org for heart failure and cardiomyopathies. His research focus over the last several years has been on risk stratification in heart failure, cardiac amyloidosis, and cardio-oncology cohorts.
Read the full manuscript here:
https://heart.bmj.com/content/early/2024/01/24/heartjnl-2023-323502
Donate to the Rachel Levine Amyloidosis Awareness Fund here:
https://ic-os.info/RachelDaraLavineFund
Dr Saro Armenian is a Pediatric Hematologist-Oncologist at City of Hope's (COH) main campus Duarte, US. He co-leads the COH Cancer Control and Population Sciences Program and directs the Center for Survivorship and Outcomes in the Hematologic Malignancies Research Institute.
Dr Michelle Kittleson is Professor of Medicine at Cedars-Sinai and Director of Education in Heart Failure and Transplantation at the Smidt Heart Institute. She graduated from Harvard College and received her medical degree from Yale University. She completed residency training at Brigham and Women's Hospital and cardiology fellowship at Johns Hopkins, where she also received a PhD in Clinical Investigation.
Watch the complete webinar here: https://www.radcliffecardiology.com/webinars/latest-clinical-trial-updates-attr-cm-and-al-cm
Dr. Paul Cottu, oncologist at Institut Curie, Paris, FR provides an overview of breast cancer therapies with associated cardiovascular toxicities. The original webinar can be viewed at the link below:
https://www.radcliffecardiology.com/webinars/cardiotoxicity-breast-cancer-challenges-multimodal-therapies
Dr Anne Blaes is a Professor in the Division of Hematology and Oncology at the University of Minnesota. She is the Director of the Screening, Prevention, Etiology, and Cancer Survivorship (SPECS) Program within the Masonic Cancer Center.
View the original webinar here:
https://www.radcliffecardiology.com/webinars/applying-esc-ic-os-guidelines-how-do-we-actually-do-risk-stratification
Ihab Rafic Hamzeh, MD, Associate Professor, Department of Cardiology, The MD Anderson Cancer Center, Houston, TX
This is a highlight from our weekly webinar January 11, 2023. You can view the entire broadcast at the link below.
https://www.radcliffecardiology.com/webinars/cardiovascular-toxicities-novel-cancer-drugs
Dr Kathryn Ruddy is a Professor of Oncology at Mayo Clinic, Rochester, US. She co-leads the Prevention, Survivorship and Care Delivery Programme at Mayo Clinic Comprehensive Cancer Center.
Dr. Ganatra and Dr. Daniel Lenihan discuss an article they both contributed to titled "SGLT2 Inhibitor Use and Risk of Clinical Events in Patients With Cancer Therapy–Related Cardiac Dysfunction"
Article Link
https://www.sciencedirect.com/science/article/abs/pii/S2213177923005966
Dr. Sarju Ganatra is Vice Chair of the Department of Medicine at Lahey Hospital Department of Medicine Research
Follow him on X:
@SarjuGanatraMD
Dan Lenihan and Steve Casselli had a chance to sit down with Dr. Prince Otchere at the San Antonio Breast Cancer Summit 2023 and discuss developments in Ghana, Africa which Prince is helping to pioneer.
We had the chance to sit down with Dr. Icro Meattini from Florence, Italy to hear about his experience as a Radiation Oncologist from Italy along with his insights about the SABCS meeting.
Dr. Susan Dent, Dr. Teresa Lopez-Fernandez speak with IC-OS Executive Director Steve Casselli about community highlights from the past year.
This is a brief discussion recorded at the American Heart Association in Philadelphia, USA.
Teresa López-Fernández is a clinical investigator and consultant cardiologist at La Paz University Hospital in Madrid, Spain. She is specializes in cardiac imaging and cardio-oncology (she is board certified by the International Cardio-Oncology Society), and currently coordinates the cardio-oncology team at La Paz University Hospital.
Dr. Joseph Carver is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, the Chief Operating Officer of the Abramson Family Cancer Research Institute of the Abramson Cancer Center of the University of Pennsylvania and the Chief of Staff of the Abramson Cancer Center.
He is also an editor of the Cardio-Oncology Journal. For submission information and to read the latest science go to: https://cardiooncologyjournal.biomedcentral.com/
Dr. Michael Fradley speaks about the role of electrophysiology in cardio-oncology from the American Heart Association meeting in Philadelphia, USA.
Dr. Abdelrahman Ali, Cardio-Oncology Fellow speaks with Dr. Daniel Addison and Dr. Daniel Lenihan at the AHA meeting in Philadephia about Dr. Addison's presentation on health equity.
Juan Lopez-Mattei is Medical Director and Director of Cardiac Imaging, Lee Health Heart & Vascular Institute,
Cardiac computed tomographic imaging in cardio-oncology: An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT). Endorsed by the International Cardio-Oncology Society (ICOS)
https://pubmed.ncbi.nlm.nih.gov/36216699/
Dr. Daniel Lenihan, Saint Francis Healthcare System, Cape Girardeau, US
Dr. Giovanni Palladini, Associate Professor of Clinical Chemistry The University of Pavia, Pavia, IT
Dr. Richard Cheng, Associate Professor of Medicine/Cardiology and Radiology,University of Washington, Seattle, US
Dr. Ashutosh Wechalekar, senior lecturer and honorary consultant haematologist, University College London and the Royal Free London NHS Foundation Trust, UK
Discuss promising new therapies for AL Amyloidosis
Joshua Mitchell, MD, MSCI is an Assistant Professor of Medicine and Co-Director of the Amyloid Center of Excellence at Washington University School of Medicine in St. Louis. He also serves as the Director of the Cardio-Oncology Center of Excellence and Cardio-Oncology Fellowship.
RESOURCES:
Original Webinar: https://www.radcliffecardiology.com/video-index/ic-os-weekly-webinar-evaluation-and-management-cardiotoxicity-radiation-therapy
Related Article: Cardiovascular Manifestations From Therapeutic Radiation: A Multidisciplinary Expert Consensus Statement From the
International Cardio-Oncology Society
https://www.jacc.org/doi/10.1016/j.jaccao.2021.06.003
Dr. Rebecca Roylance Consultant Medical Oncologist and Honorary Associate Professor at University College London Hospital
Dr. Andrew Wilson Consultant Hematologist and honorary associate professor at University College London Hospital
Andrew and Rebecca discuss clinical management of patients and how they collaborate with their cardiology colleagues in daily practice.
Tomas G. Neilan, MD, MPH discusses the broad spectrum of biomarkers that can be used to detect ICI mediated myocarditis.
Dr. Neilan is an Associate Professor of Medicine at Harvard Medical School, a cardiologist at MGH, the director of the Cardio-Oncology Program at MGH and the co-director of the Cardiovascular Imaging Research Center. He holds the Michael and Kathyrn Park Chair in Cardiology. He is a physician scientist and a board-certified cardiologist. He completed his medical school training at University College Dublin Medical School, his clinical training in Internal Medicine and Cardiology at the Mater Hospital in Dublin and repeated his training in Internal Medicine and Cardiology at MGH. He has also competed advanced training in echocardiography at MGH, a clinical and research fellowship in cardiac MRI at BWH, and a Master’s in Public Health at the Harvard School of Public Health. His career has had two major focuses: 1) Understanding how we can improve the cardiovascular care of patients with cancer and 2) The use of advanced imaging to better understand and characterize cardiovascular disease. He has authored or co-authored more than 150 original manuscripts, 40 review articles, has presented over 400 abstracts at international meetings, and has lectured at major national and international meetings. Dr. Neilan has been awarded the “de Gunzburg Family Endowed Scholar in Cardiology”, The Locke Award for excellence in medical education and elected as a Senior Fellow to the Oliver Wendell Holmes Society at Harvard Medical School.
Dr. Nicolas Palaskas surveys emerging therapies for treating immune checkpoint inhibitor myocarditis, a rare but life threatening condition.
Nicolas Palaskas MD is an Assistant Professor of Medicine in the Department of Cardiology. Dr. Palaskas completed cardiology fellowship (2017) and internal medicine residency (2014) at Baylor College of Medicine. He joined MD Anderson Cancer Center in 2017 immediately following completion of fellowship. His clinical interests include cancer therapeutic cardiotoxicity management, echocardiography, and cardiac catheterization for patients with cancer. In addition, Dr. Palaskas leads institutional efforts in immunotherapy cardiotoxicity. His main research focus is on immune checkpoint inhibitor-related myocarditis for which he has three grants related to the diagnosis and surveillance of myocarditis; Cancer Prevention & Research Institute of Texas Early Clinical Investigator Award (2020), Sabin Family Foundation Fellowship (2020), and Division of Internal Medicine Research Development Award (2019).
Watch the whole webinar here:
https://wondrmedical.net/ch/IC-OS/videos/Ic-Os-Weekly-Webinar-Immune-Checkpoint-ED84B7881
In this episode we speak with the Chair of the IC-OS Center of Excellence Certification Committee Dr. Vijay Rao who explains the history, rationale and benefits of becoming an IC-OS Center of Excellence.
Dr. Rao completed his MD and PhD at the Medical University of South Carolina, Internal Medicine residency at Duke University Medical Center, followed by Cardiology fellowship at the University of California, San Francisco. He is the Director of the CardioOncology, Heart Failure, and Anticoagulation clinics at Franciscan Health in Indianapolis, Indiana. He serves as Chair of the IC-OS Center of Excellence Committee and is an active member of the IC-OS education committee. The Franciscan CardioOncology program won the Association of Community Cancer Centers (ACCC) national Innovator Award in 2019 and was selected as an IC-OS Center of Excellence: Gold Status in 2022. He was also the lead author on a JACC: State of the Art Review on Cardiovascular Toxicity of Oral Antineoplastic Agents in 2021 and is the Governor-Elect of the Indiana Chapter of the American College of Cardiology.
Darryl Leong is a Scientist at PHRI, Director of the McMaster University and Hamilton Health Sciences Cardio-Oncology Program, Associate Professor, Department of Medicine (Cardiology), McMaster University, and Staff Cardiologist at Hamilton Health Sciences. He has methodological expertise in clinical epidemiology and clinical trials, and content expertise in physical frailty, echocardiography, and cardio-oncology.
Sarah Maryon Hayes Pharm D. is a Board-Certified Oncology Pharmacist at North Memorial Health Care in Minneapolis, MN. She is passionate about patient-directed cancer care and late-breaking research in clinical pharmacy, inpatient supportive care, and Hematology/Oncology practice. She completed her PGY-2 Hematology/Oncology Residency at the University of Minnesota Medical Center and serves as a lecturer at the University of Minnesota College of Pharmacy.
Dr. Tochi Okwuosa
Professor Department of Internal Medicine, RUSH Medical College
Director, Cardio-Oncology Services
Dr. Okwuosa discusses disparities in Cardio-Oncology care with Dr. Arjun Ghosh an Dr. Daniel Lenihan.
To view this spotlight go to: https://wondrmedical.net/ch/IC-OS/videos/How-To-Measure-Blood-Pressure-Accurately-D4A37A482
This is the first in a new series of spotlights taken from our weekly webinars. In this spotlight Dr. Darryl Leong Associate Professor, Department of Medicine, McMaster University discusses the use of biomarkers in the treatment of patients with prostate cancer.
View and join all our weekly webinars at the link below by simply following our channel on Wondr Medical:
https://wondrmedical.net/ch/IC-OS#
View the complete webinar on the use of biomarkers in prostate cancer treatment here:
https://wondrmedical.net/ch/IC-OS/videos/Live-How-To-Use-Cardiac-And-Oncologic-M-BF437E78E
Recently Dr. Charlie Porter published a landmark article in JACC Cardio-Oncology titled "Permissive Cardiotoxicity: The Clinical Crucible of Cardio-Oncology"
You can read the article here
Spain - Teresa López-Fernández, MD is a clinical investigator and consultant cardiologist at La Paz University Hospital in Madrid, Spain.
Brazil -
Renato Lopes, MD, Professor of Medicine. Member in the Duke Clinical Research Institute, USA
Carolina Silva, MD, PhD, cardio-oncologist, consultant cardiologist, clinical investigator at Brazilian Clinical Research Institute
Ariane Vieira Scarlatelli Macedo, MD, MHSAssistant physician and coordinator of the cardio-oncology clinic at Santa Casa de São Paulo School of Medicine, São Paulo, Brazil
United Kingdom - Mark Westwood, MD, consultant cardiologist at OneWelbeck Heart Health, specializing in cardiac MRI and cardio-oncology.
We welcome Dr. Darryl Leong Associate Professor, Medicine, Director of the McMaster University and Hamilton Health Sciences Cardio-Oncology Program and Chair of the ICOS Research Working Group with Dr. Tia Higano Adjunct Professor, Department of Urologic Sciences, University of British Columbia, to discuss developments in prostate cancer research and the new ESC-ICOS Guideline in Cardio-Oncology.
Delegates from around the world share their reflections from the 2022 GCOS meeting in Toronto, Canada October 5-7 including: Kerry Skurka, RN (USA), Trent Williams, RN (Australia), Christine Brezden-Masley, MD (Canada), Stefanie Mundnich, MD (Chile), Ana Barac, MD (USA), Dan Gilon, MD (Israel), Zaza Iakobishvili, MD (Israel), Edith Pituskin, PhD (Canada), Anecita Fadol, PhD (USA), Giselle Melendez, MD (USA), Juliana Salas Segura, MD (Costa Rica), Alex Lyon, MD (United Kingdom), Karlis Trusinskis, MD (Latvia), Trishun Singh, MD (South Africa), Susan Dent, MD (USA), Teresa Lopez-Fernandez (Spain)
Co-Chair for the ESC Guidelines and IC-OS Vice President Teresa Lopez-Fernandez discusses the development, value and impact of the definitive guidelines in the field of cardio-oncology.
You can read the guidelines here: https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehac244/6673995?login=false#369610645
Leaders of the IC-OS Pharmacy Working Group Heather N. Moore, PharmD, BCOP, CPP, Clinical Oncology Pharmacist, Breast Oncology, Duke University Medical Center and Craig Beavers, PharmD, Assistant Professor of Pharmacy Science at University of Kentucky discuss the role of the pharmacist in the care of cardio-oncology patients.
Dra. Roberta Szor hematologist at the Sao Paulo Cancer Institute – University of Sao Paulo and Dra. Ariane Macedo Chair of the Cardio-oncology clinic at Santa Casa in São Paulo and a researcher at Brazilian Clinical Research Institute discuss their work in Amyloidosis.
To view educational resources on Amyloidosis see:
https://www.francefoundation.com/zebra-or-a-horse-full-webinars
In this episode we are replaying a recording of our IC-OS Australia chapter President Dr. Daniel Cehic. Originally recorded in October 2021 for the Medical Republic, we are glad to be able to repost this discussion about the impact of radiation therapy in cardio-oncology patients.
You can find the original recording here: https://medicalrepublic.com.au/heart-problems-a-bump-in-the-road-for-remission/55584
The editors of the new Washington Manual of Cardio-Oncology (Daniel Lenihan, MD, Joshua Mitchell, MD, Kathleen Zhang, MD) discuss the contours and value of this important publication.
Order the volume here:
https://www.amazon.com/Washington-Manual-Cardio-Oncology-Practical-Survivorship/dp/1975180445/ref=sr_1_1?crid=3MR0OE7LGRHIP&keywords=lenihan+washington+manual+cardio-oncology&qid=1651765072&sprefix=lenihan+washington+manual+cardio-oncology%2Caps%2C73&sr=8-1
We are joined today by the co-chairs of the IC-OS Exercise Working Group to discuss the role of exercise as a therapy for cardio-oncology patients.
Dr. Erin Howden is the head of the Human Integrative Physiology Lab, co-lead of the Physical Activity Program at the Baker Heart and Diabetes Institute, Melbourne Australia.
Dr. Scott Adams is an assistant Scientist at Toronto General Hospital Research Institute and exercise lead at the Ted Rogers Cardiotoxicity Prevention Program in Toronto, Canada.
In this episode a reference was made to the following article:
Florez Bedoya CA, Cardoso ACF, Parker N, et al: Exercise during preoperative therapy increases tumor vascularity in pancreatic tumor patients. Scientific Reports 9:13966, 2019
The International Cardio-Oncology Society has a pediatrics working group led by Dr. Veronica Santos (Brazil) and Dr. Neha Bansal (USA). Today they discuss their experience and developments in pediatric cardio-oncology.
Susan Strong - founding President and current Director of Patient Engagement for Heart Valve Voice US
https://www.heartvalvevoice-us.org/
Kreena Dhiman - Cancer and heart failure survivor and cardio-oncology advocate
https://www.instagram.com/kreenadhiman/?hl=en
https://www.kreenadhiman.com/
Dr. Harrison is a cardiologist serving in private practice in Tampa, FL. He is the chairman of the board of the International Cardio Oncology Society and a pioneer in the field. In this episode he reflects on his own early experience, the growth and the future of the discipline.
Dr. Dharini Ramu, Associate Professor of Medicine at the Medical University of South Carolina, practicing advanced heart failure, leading the cardio-oncology program and serving as co-medical director of the Cardiac ICU.Richard Cheng, et al. “Implications of cancer prior to and after heart transplantation”
Richard Cheng, Associate Professor of Medicine/Cardiology and Adjunct Associate Professor of Radiology at University of Washington/Seattle Cancer Care Alliance, Program Director for the Advanced Heart Failure Fellowship, Director of the Cardio-oncology Program
Related Articles:
Richard Cheng, et al. “Implications of cancer prior to and after heart transplantation”
https://heart.bmj.com/content/early/2021/06/30/heartjnl-2020-318139
Richard Cheng, et al. “Cardio-Oncology and the Intersection of Cancer and Cardiotoxicity: The Role of Palliative Care”
https://www.jacc.org/doi/10.1016/j.jaccao.2019.10.003
Bhavadharini Ramu, et. al. “Heart Transplantation in Adriamycin-Associated Cardiomyopathy in the Contemporary Era of Advanced Heart Failure Therapies” https://www.jacc.org/doi/10.1016/j.jaccao.2021.02.010
Learn more about the Global Cardio-Oncology Summit 2021- Virtual as Steve & Arjun discuss the upcoming meeting with one of its principal organizers, Dr. Michael Fradley, UPenn, USA.
Steve & Arjun discuss cardio-oncology nursing with Anecita Fadol, PhD, FNP, FAANP, FAAN, Associate Professor, Departments of Nursing and Cardiology, MD Anderson Cancer Center, Houston, Texas, USA and RN Alison Macklin, Cardio-Oncology Specialist Nurse & Research Nurse University College London Hospital, UK.
Text Book:
https://www.amazon.com/Cardiac-Complications-Cancer-Therapy-Anecita/dp/1935864246
Dr. Arjun Ghosh, Dr. Susannah Stanway and Dr. Rebecca Dobson, co-authors of the new "BSE and BCOS Guideline for Transthoracic Echocardiographic Assessment of Adult Cancer Patients Receiving Anthracyclines and/or Trastuzumab" discuss their work.
Read the Guideline here: https://www.jacc.org/doi/pdf/10.1016/j.jaccao.2021.01.011
Today Steve & Arjun speak with Dr. Cezar Iliescu, Interventional Cardiology, Medical Director MD Anderson Cardiac Catheterization Laboratory, President and Founder of INOCS (INterventional Onco-Cardiology Society), and Dr. Kostas Marmagiolis- Associate Professor of Cardiology at MD Anderson, and Interventional Cardiologist at Northside Hospital in St. Petersburg, Florida about the pioneering work they are doing in interventional cardiology for cancer patients.
For more information on their organization: INOCS.org
Contact information:
Dr. Iliescu: ciliescu@mdanderson.org
Dr. Marmagiolis: cmarmagiolis@gmail.com
Dr. Arjun Ghosh speaks with Dr. Michael Fradley Medical Director, Penn Cardio-Oncology Program, Associate Professor of Clinical Medicine at the University of Pennsylvania and Dr. Kaveh Karimzad Associate Professor Department of Cardiology, Director of Electrophysiology, Director of Cardiac Device (CIEDs) clinic at MD Anderson Cancer Center, in Houston, Texas about the role and opportunities in electrophysiology for the care for cardio-oncology patients.
Dr. Ashutosh Wechalekar together with Dr. Arjun Ghosh discusses his work at the National Amyloid Center in London, including what they have learned about the diagnosis and treatment of Amyloidosis.
Guests:
Dr. Arjun Ghosh consultant cardiologist at Barts Heart Centre, University College London Hospital and the Hatter Cardiovascular Institute
Prof. Ashutosh Wechalekar Professor of Medicine and Haematology, University College London and the Royal Free London NHS (National Health Service) Foundation Trust
Links:
ICOS Webinars: http://ic-os.org/webinar_registration/
Amyloidosis Resources:
https://www.ucl.ac.uk/amyloidosis/national-amyloidosis-centre
http://amyloidosismutations.com/
www.amyloidosis.org.uk
https://www.myeloma.org.uk/understanding-myeloma/related-conditions/al-amyloidosis/
https://arci.org/
In this episode we hear about the cardio-oncology experience from the perspective of the cancer survivor. Thirty years after cancer therapy, Dennis began to experience heart trouble. He put the pieces together and recounts his journey for us.
Teresa Lopez-Fernandez, President of IC-OS Spain discusses the upcoming Virtual Cardio-Oncology Summit (VCOS) October 1, 2020.
For further information: http://www.vcos2020.org/VCOS2020
Dr. Susannah Stanway Consultant in Medical Oncology in the Breast Unit at the Royal Marsden NHS Foundation Trust speaks about her work in cardio-oncology including her involvement with lower and middle income nations.
Information about the London Global Cancer Week can be found here: https://www.lgcw.org.uk/
Article: "Baseline cardiovascular risk assessment in cancer patients: Cardio‐Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio‐Oncology Society" https://onlinelibrary.wiley.com/doi/abs/10.1002/ejhf.1920
Dr. Giuseppe Curigliano, Assoc. Professor of Medical Oncology, University of Milan, Italy, discusses Cardio-Oncology practice during the COVID pandemic with the President of ICOS, Dr. Daniel Lenihan, Washington University of St. Louis.
Dr. Greg Armstrong addresses recent research related to the impact of cancer therapies on survivors of childhood cancer. Below are links to some of the research we discuss on the program.
For the full text of "Therapy-Related Cardiac Risk in Childhood Cancer Survivors: An Analysis of the Childhood Cancer Survivor Study" go here:
https://www.ncbi.nlm.nih.gov/pubmed/30860946
For longterm follow up guidelines for childhood cancer survivors go here:
http://www.survivorshipguidelines.org/pdf/2018/COG_LTFU_Guidelines_v5.pdf
Today we speak with Dr. Trishun Singh, President of ICOS South Africa and Dr. Sebastian Szmit, President of ICOS Poland about the first cardio oncology conference on the continent of Africa.
To learn more about Dr. Singh's work in South Africa go to:
https://www.pressreader.com/south-africa/post-south-africa/20200304/281921660093356
Dr. Daniel Lenihan has been working with a global team to create the first Cardio-Oncology certification exam. Here we learn more about the origin, purpose, and plans for this exciting development.
Application for the Exam can be found here: http://ic-os.org/board-certification/
Dr. Roohi Ismail-Khan and Dr. Michael Fradley discuss their work in establishing the joint Cardio Oncology program at the University of South Florida and the H. Lee Moffitt Cancer Center and Research Institute, in Tampa, FL. They discuss the many advantages for patients who have access to programs like this.
In this our pioneer episode, we speak with Dr. Daniel Lenihan of Washington University about the history, growth and future of Cardio Oncology.